The photo is taken from open sources: https://smolinvest.ru/projects/ooo-dragbiofarm/#pid=1
During the XXV St. Petersburg International Economic Forum, the Administration of the Smolensk Region and Dragbiopharm LLC signed an agreement on cooperation in the implementation of an investment project for the construction of a plant for the production of active pharmaceutical substance (hereinafter referred to as API) Heparin and its derivatives in the territory of the Dorogobuzhsky District municipality of the Smolensk Region.
The project is significant for the pharmaceutical industry of the Russian Federation, and the products produced under the project are included in the action plan for import substitution in the pharmaceutical industry.
At the moment, the project has successfully passed the state examination and received a positive conclusion.
